Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study (Q33426973)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study |
scientific article |
Statements
1 reference
Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study (English)
1 reference
Edwin M Posadas
1 reference
Rafi S Ahmed
1 reference
Theodore Karrison
1 reference
Russell Z Szmulewitz
1 reference
Peter H O'Donnell
1 reference
James L Wade
1 reference
James Shen
1 reference
Murali Gururajan
1 reference
Margarit Sievert
1 reference
Walter M Stadler
1 reference
23 October 2015
1 reference
1 reference
76
1 reference
286-293
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference